(NASDAQ: ZURA) Zura Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 71.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.45%.
Zura Bio's earnings in 2025 is -$62,520,000.On average, 9 Wall Street analysts forecast ZURA's earnings for 2025 to be -$50,074,449, with the lowest ZURA earnings forecast at -$49,066,588, and the highest ZURA earnings forecast at -$50,523,110. On average, 9 Wall Street analysts forecast ZURA's earnings for 2026 to be -$51,400,925, with the lowest ZURA earnings forecast at -$56,713,329, and the highest ZURA earnings forecast at -$47,792,131.
In 2027, ZURA is forecast to generate -$47,089,880 in earnings, with the lowest earnings forecast at -$59,899,471 and the highest earnings forecast at -$22,530,576.